Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-33111

Aguzzi, A; O'Connor, T (2010). Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nature Reviews. Drug Discovery, 9(3):237-248.

[img] PDF - Registered users only
2MB

Abstract

A growing number of diseases seem to be associated with inappropriate deposition of protein aggregates. Some of these diseases--such as Alzheimer's disease and systemic amyloidoses--have been recognized for a long time. However, it is now clear that ordered aggregation of pathogenic proteins does not only occur in the extracellular space, but in the cytoplasm and nucleus as well, indicating that many other diseases may also qualify as amyloidoses. The common structural and pathogenic features of these diverse protein aggregation diseases is only now being fully understood, and may provide novel opportunities for overarching therapeutic approaches such as depleting the monomeric precursor protein, inhibiting aggregation, enhancing aggregate clearance or blocking common aggregation-induced cellular toxicity pathways.

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Neuropathology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2010
Deposited On:26 Mar 2010 09:45
Last Modified:27 Nov 2013 18:49
Publisher:Nature Publishing Group
ISSN:1474-1776
Publisher DOI:10.1038/nrd3050
PubMed ID:20190788
Citations:Web of Science®. Times Cited: 140
Google Scholar™
Scopus®. Citation Count: 146

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page